Recombinant gdnf

Manufactured by Thermo Fisher Scientific

Recombinant GDNF is a laboratory product that provides the Glial Cell Derived Neurotrophic Factor (GDNF) protein. GDNF is a growth factor that supports the survival and maintenance of various types of neurons. This recombinant protein can be used for cell culture and research applications.

Automatically generated - may contain errors

Lab products found in correlation

Hx531, by Bio-Techne (2 mentions) Smartpool sirna, by Horizon Discovery (2 mentions) Brafi dabrafenib, by MedChemExpress (2 mentions) Meki trametinib, by MedChemExpress (2 mentions) Faki pf562271, by MedChemExpress (2 mentions)

Close spelling variants of this product

Recombinant human GDNF (17 citations) Recombinant Murine GDNF (5 citations) Recombinant Human Glial-Derived Neurotrophic Factor (GDNF, (3 citations) Recombinant rat GDNF (3 citations)

2 protocols using recombinant gdnf

Evaluating Targeted Therapeutic Combinations

Check if the same lab product or an alternative is used in the 5 most similar protocols

BRAFi Dabrafenib, MEKi Trametinib and FAKi PF562271 were purchased from MedChemExpress, RXR antagonist HX531 from Tocris, siRNA SMARTpools from Dharmacon (siRNA sequences are available upon request), recombinant GDNF from Peprotech.

Marin-Bejar O., Rogiers A., Dewaele M., Femel J., Karras P., Pozniak J., Bervoets G., Van Raemdonck N., Pedri D., Swings T., Demeulemeester J., Borght S.V., Lehnert S., Bosisio F., van den Oord J.J., Bempt I.V., Lambrechts D., Voet T., Bechter O., Rizos H., Levesque M.P., Leucci E., Lund A.W., Rambow F, & Marine J.C. (2021). Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma. Cancer cell, 39(8).

+ Open protocol

+ Expand

Evaluating Targeted Therapeutic Combinations

Check if the same lab product or an alternative is used in the 5 most similar protocols

Marín-Béjar O., Rogiers A., Dewaele M., Femel J., Karras P., Poźniak J., Bervoets G., Raemdonck N.V., Pedri D., Swings T., Demeulemeester J., Pelt J.v., Bosisio F.M., Oord J.J.v.d., Bempt I.V., Lambrechts D., Voet T., Bechter O., Rizos H., Levesque M.P., Leucci E., Lund A.W., Rambow F., & Marine J. (2020). A neural crest stem cell-like state drives nongenetic resistance to targeted therapy in melanoma.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!